Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7985844 | 0.95 | GAA (0.52) | GAAALDH1A1HPGDAURKATP53 | |
| SCHEMBL7974016 | 0.94 | GAA (0.56) | GAAALDH1A1HPGDSMN1; SMN2KMT2A | |
| SCHEMBL7991871 | 0.92 | GAA (0.51) | GAAALDH1A1HPGDSMN1; SMN2KMT2A | |
| SCHEMBL7991542 | 0.92 | GAA (0.50) | GAAALDH1A1HPGDSMN1; SMN2AURKA | |
| SCHEMBL7985355 | 0.92 | GAA (0.56) | GAAALDH1A1HPGDSMN1; SMN2KMT2A | |
| SCHEMBL7974193 | 0.91 | GAA (0.49) | GAAALDH1A1HPGDSMN1; SMN2AURKA | |
| SCHEMBL7985371 | 0.91 | GAA (0.49) | GAAALDH1A1HPGDKMT2ANPSR1 | |
| SCHEMBL7974404 | 0.91 | SMN1; SMN2 (0.49) | GAAALDH1A1HPGDSMN1; SMN2KMT2A | |
| SCHEMBL7974092 | 0.90 | GAA (0.51) | GAAALDH1A1HPGDSMN1; SMN2KMT2A | |
| SCHEMBL7985575 | 0.90 | HPGD (0.49) | GAAHPGDSMN1; SMN2NPSR1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |